All articles

Enclomiphene vs Clomiphene: What the Difference Actually Changes

Reading time:

9 min

Published on

Updated on

Resources

Ready to transform your health?

Ready to transform your health?

Get expert guidance and a personalized care plan designed around you.

Key Takeaways

  • Clomiphene citrate is a mixture of two closely related molecules, about 62% enclomiphene and 38% zuclomiphene. Enclomiphene is not a rival to clomiphene, it is the part thought to do most of the useful work, though the two have never been compared head to head.

  • Enclomiphene raises the two hormone signals that tell your testicles to make testosterone. Zuclomiphene acts a little like estrogen instead, and clears far more slowly.

  • Because zuclomiphene lingers, it builds up over months until it outnumbers the part driving the testosterone response. That is the main argument for taking enclomiphene alone.

  • Neither drug is FDA-approved for low testosterone in men. Clomiphene is approved only for women trying to get pregnant, and enclomiphene has no approval at all.

  • A 2025 review of 10 trials grouped the two drugs together instead of testing one against the other, so the case for enclomiphene rests on how it behaves, not on a head-to-head study.

Both are taken orally, usually once a day. Neither is testosterone: rather than adding the hormone from outside, they nudge your own body into making more of it.

Anyone comparing the two usually starts with a reasonable but wrong assumption: that these are rival drugs. Enclomiphene is a piece of clomiphene, separated out and sold on its own.

They work the same way. Estrogen normally acts as a brake on the brain, telling it to ease off the signals that drive testosterone production. Both drugs block that brake.

Your pituitary gland then releases more of two signalling hormones, LH and FSH, and your testicles respond by making more testosterone and more sperm. That is why doctors use these drugs instead of giving testosterone directly. 

So the useful question is narrower: does dropping zuclomiphene change how you feel, how well it works, or how safe it is?

Key Takeaways

  • Clomiphene citrate is a mixture of two closely related molecules, about 62% enclomiphene and 38% zuclomiphene. Enclomiphene is not a rival to clomiphene, it is the part thought to do most of the useful work, though the two have never been compared head to head.

  • Enclomiphene raises the two hormone signals that tell your testicles to make testosterone. Zuclomiphene acts a little like estrogen instead, and clears far more slowly.

  • Because zuclomiphene lingers, it builds up over months until it outnumbers the part driving the testosterone response. That is the main argument for taking enclomiphene alone.

  • Neither drug is FDA-approved for low testosterone in men. Clomiphene is approved only for women trying to get pregnant, and enclomiphene has no approval at all.

  • A 2025 review of 10 trials grouped the two drugs together instead of testing one against the other, so the case for enclomiphene rests on how it behaves, not on a head-to-head study.

Both are taken orally, usually once a day. Neither is testosterone: rather than adding the hormone from outside, they nudge your own body into making more of it.

Anyone comparing the two usually starts with a reasonable but wrong assumption: that these are rival drugs. Enclomiphene is a piece of clomiphene, separated out and sold on its own.

They work the same way. Estrogen normally acts as a brake on the brain, telling it to ease off the signals that drive testosterone production. Both drugs block that brake.

Your pituitary gland then releases more of two signalling hormones, LH and FSH, and your testicles respond by making more testosterone and more sperm. That is why doctors use these drugs instead of giving testosterone directly. 

So the useful question is narrower: does dropping zuclomiphene change how you feel, how well it works, or how safe it is?

Enclomiphene vs Clomiphene: The Short Answer

Removing zuclomiphene should mean fewer estrogen-related side effects while keeping the testosterone benefit, though almost no studies have compared the two directly. The difference matters over months, not weeks, because a single week of either does much the same thing.

Enclomiphene vs Clomiphene: The Short Answer

Removing zuclomiphene should mean fewer estrogen-related side effects while keeping the testosterone benefit, though almost no studies have compared the two directly. The difference matters over months, not weeks, because a single week of either does much the same thing.

Zuclomiphene: The Part that Drives the Difference

Clomiphene citrate is not one molecule but a mixture of two closely related ones, roughly 62% and 38%, as Rodriguez, Pastuszak and Lipshultz set out in Expert Opinion on Pharmacotherapy in 2016, and anyone taking clomiphene gets both in a fixed ratio they cannot adjust.

The two behave differently. Enclomiphene is the half that raises those two signals, the effect a provider is after in a man with low testosterone. Zuclomiphene acts a little like estrogen rather than purely blocking it, so it works partly against the goal.

Then there is timing, the heart of the comparison. Zuclomiphene lingers. Its half-life, the time it takes for half a dose to clear your system, is about 30 days. For enclomiphene overall it is roughly 10 hours.

So, enclomiphene levels settle quickly while zuclomiphene keeps stacking up with each daily dose.

In a 2017 study in BJU International, in men who took clomiphene long term, zuclomiphene eventually became the dominant one. The same build-up was already documented in women over repeated treatment cycles.

So a man who has taken clomiphene for a year is not getting the same mixture at month twelve that he got in week one. The researchers argued for a pure version of the useful half, which is what enclomiphene is. That is convincing about how the drugs behave, but it is not proof that patients do better.

Zuclomiphene: The Part that Drives the Difference

Clomiphene citrate is not one molecule but a mixture of two closely related ones, roughly 62% and 38%, as Rodriguez, Pastuszak and Lipshultz set out in Expert Opinion on Pharmacotherapy in 2016, and anyone taking clomiphene gets both in a fixed ratio they cannot adjust.

The two behave differently. Enclomiphene is the half that raises those two signals, the effect a provider is after in a man with low testosterone. Zuclomiphene acts a little like estrogen rather than purely blocking it, so it works partly against the goal.

Then there is timing, the heart of the comparison. Zuclomiphene lingers. Its half-life, the time it takes for half a dose to clear your system, is about 30 days. For enclomiphene overall it is roughly 10 hours.

So, enclomiphene levels settle quickly while zuclomiphene keeps stacking up with each daily dose.

In a 2017 study in BJU International, in men who took clomiphene long term, zuclomiphene eventually became the dominant one. The same build-up was already documented in women over repeated treatment cycles.

So a man who has taken clomiphene for a year is not getting the same mixture at month twelve that he got in week one. The researchers argued for a pure version of the useful half, which is what enclomiphene is. That is convincing about how the drugs behave, but it is not proof that patients do better.

FDA Status: Neither is Approved for Men

Clomiphene is FDA-approved, but not for this. It is approved only for women, to trigger ovulation in those trying to get pregnant. Prescribing it to raise testosterone in men is off-label. That is legal and common, but it means the label carries no dosing or safety guidance for this use.

Enclomiphene has no FDA approval at all. The FDA turned it down for low testosterone in men, saying a rise in testosterone by itself was not enough evidence. The agency later reviewed it for compounding. Its Pharmacy Compounding Advisory Committee voted in June 2022 against adding enclomiphene to the 503A Bulks List, the agency has not issued a final decision, and the substance remains in Category 1, still under evaluation. In the US it is only available as a compounded medication, and compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality.

The British Society for Sexual Medicine takes a similar line. It calls enclomiphene promising for men who want to protect their fertility, while warning that it is unlicensed and best handled by specialists.

FDA Status: Neither is Approved for Men

Clomiphene is FDA-approved, but not for this. It is approved only for women, to trigger ovulation in those trying to get pregnant. Prescribing it to raise testosterone in men is off-label. That is legal and common, but it means the label carries no dosing or safety guidance for this use.

Enclomiphene has no FDA approval at all. The FDA turned it down for low testosterone in men, saying a rise in testosterone by itself was not enough evidence. The agency later reviewed it for compounding. Its Pharmacy Compounding Advisory Committee voted in June 2022 against adding enclomiphene to the 503A Bulks List, the agency has not issued a final decision, and the substance remains in Category 1, still under evaluation. In the US it is only available as a compounded medication, and compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality.

The British Society for Sexual Medicine takes a similar line. It calls enclomiphene promising for men who want to protect their fertility, while warning that it is unlicensed and best handled by specialists.

Evidence: What the Studies Actually Measured

The strongest evidence is a 2025 review of 10 trials by Hohl and colleagues in Archives of Endocrinology and Metabolism. Against a placebo, this class raised testosterone by about 274 ng/dL on average and clearly raised both LH and FSH. Against a testosterone gel, the testosterone difference was too small to count, while the two signals still improved.

But notice what that review did. It grouped clomiphene and enclomiphene together rather than testing one against the other. The best evidence available was never designed to answer this question.

The enclomiphene-only studies are much smaller. One dose-ranging study compared it with a testosterone gel and found that after six weeks, testosterone reached about 604 ng/dL on the highest enclomiphene dose against about 500 on the gel, with the two treatments pushing LH and FSH in opposite directions. Other work confirmed enclomiphene raises your own testosterone and keeps sperm counts up. On the clomiphene side, a long-term follow-up study found that among men treated for over three years, 88% got testosterone back to normal and 8% reported side effects, most commonly mood changes. Individual results are not guaranteed and may vary from person to person.

Neither drug was tested against the other. Review suggests fewer estrogen-type side effects on enclomiphene, but those studies are small, and small studies comparing side effects are the kind that mislead.

Fertility: Why Both Differ from Testosterone Therapy

This is the clearest advantage in the category, and both halves share it equally. Taking testosterone shuts down your body's own signals, which in turn shuts down sperm production. These drugs do the opposite: they push those signals up instead of replacing testosterone, so sperm production carries on.

That shutdown is a well-documented effect of testosterone replacement, and avoiding it is why these drugs appear in fertility-preserving plans.

The most striking result comes from a phase II trial by Wiehle and colleagues, comparing enclomiphene with a testosterone gel. After three months, every man in the testosterone gel arm had a sperm count below 20 million per mL, while every man in the enclomiphene arm stayed above 75 million. Those arms held five and seven men respectively, so treat the gap as a hint rather than a precise figure, though it points the same way as a separate review.

If protecting your fertility matters, that is the reason to have this conversation at all. Whether the drug is purified matters far less than whether testosterone is being replaced or stimulated. Both routes need follow-up blood work, so it is worth reading about testosterone treatment before deciding.

You can check your eligibility and have a licensed provider review your blood work and history.

Side Effects: What Changes Without Zuclomiphene

The side effects of the two drugs overlap heavily. The enclomiphene overview lists headache, nausea, hot flashes, mood changes, and mild blurred vision among the common ones. Less common but more serious are vision changes, raised estrogen, breast tenderness, and a possible rise in the risk of blood clots.

The theory is that dropping zuclomiphene should ease the estrogen-driven ones: mood changes, breast tenderness, and lower sex drive. That follows from how it behaves, and the 2026 British Society for Sexual Medicine position statement reports lower rates of these. What does not exist is a large study that put men on one version or the other and counted symptoms.

Two cautions either way. Any change in your vision means stop and call your provider. And neither drug suits people with liver disease, a history of blood clots, testicular failure, or hormone-sensitive cancers, and neither is for women or children.

This is not a complete list of possible side effects. Talk to a licensed provider about the risks of any medication, and tell them about any side effects you experience.

Getting It: The Practical Difference

Getting hold of the two differs more than the drugs themselves do, and this is often what decides it.

Clomiphene is an approved product with generics, so any regular pharmacy can fill it. Because using it in men is off-label, insurance handling varies by plan, and a provider can help you check.

Enclomiphene has no approved product to dispense, so it comes from a compounding pharmacy, and compounded medications usually sit outside standard insurance drug lists. If your plan wants prior authorization, that normally means documenting your diagnosis, past lab results, and treatments already tried. A refusal can usually be appealed. Mochi's team can help submit prior authorizations on a member's behalf where a plan requires one.

One warning. Enclomiphene sold online without a prescription, often labelled a research chemical or sold alongside peptide therapy products, is not a pharmacy product. It is also not a peptide, but a different kind of molecule entirely, and unrelated to compounds like KPV.

Blood Tests: What a Provider Checks First

Neither drug is a sensible first step without blood work because they only help one situation.

These drugs work by pushing your pituitary gland harder, which only helps if the pituitary and the testicles can still respond. Doctors call that secondary hypogonadism: the machinery works, but the signal reaching it is too weak. If the testicles themselves have failed, pushing harder achieves nothing, so these drugs are not an option there. Telling the two apart means measuring testosterone alongside LH and FSH, usually on more than one morning blood draw.

Providers work independently on the Mochi Health platform, and one can order those tests and talk through whether this class fits you. Common questions about visits and lab work are in the Mochi Health FAQs.

The Bottom Line

Enclomiphene vs clomiphene is not a contest between two drugs. It is a question about whether taking one ingredient out of a two-ingredient mixture is worth it, and the case for taking zuclomiphene out is a reasonable one on mechanism alone. It acts like estrogen, it takes about a month to half-clear, and it builds up until it outnumbers the part driving the testosterone response.

What is missing is the study that would settle it. The biggest review groups the two drugs together, and the enclomiphene-only studies are small. The differences that are well established are about approval and access, not about how patients do.

For most people the bigger decision sits one step up: whether to stimulate the testosterone your body already makes or replace it, because that is the choice that affects fertility. Sorting that out starts with blood work.

Check your eligibility to have a licensed provider review your blood work. You can also browse medication options, including sildenafil for men whose concern is erections rather than testosterone.

FAQs

Is enclomiphene just a cleaner version of clomiphene?

Broadly yes, with one catch. Enclomiphene is one of the two molecules in clomiphene, so it is a purified part rather than a different drug. The catch is legal: clomiphene is FDA-approved and used off-label in men, while enclomiphene must be compounded.

Is enclomiphene a steroid?

No. It is not a hormone and it does not add testosterone to your body. It blocks estrogen's braking signal so your body makes more of these signals itself, close to the opposite of how steroids work. The technical name for this kind of drug is a selective estrogen receptor modulator, or SERM.

Why would a provider still choose clomiphene?

Availability and standards. Clomiphene comes from regular pharmacies with a manufacturing standard behind it, and it has longer follow-up data in men. Enclomiphene needs a compounding pharmacy and has no approved label.

How long does zuclomiphene stay in your system?

It takes about 30 days for half a dose to clear, according to Helo and colleagues in BJU International, so clearing it fully takes months. That is why side effects blamed on zuclomiphene can hang around after you stop.



This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. Enclomiphene and clomiphene require a written prescription from a licensed provider. Speak with a provider to determine if enclomiphene or clomiphene is appropriate for you. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results are not guaranteed and may vary from person to person. All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

For iOS & Android

Start with care designed for you

Start with care designed for you

What can we help you with?

What can we help you with?

Personalized care for long-term wellness

Small wins add up to big transformations. Mochi reminds us to focus on what’s good and use it to build the life we envision.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

Personalized care for long-term wellness

Small wins add up to big transformations. Mochi reminds us to focus on what’s good and use it to build the life we envision.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

Personalized care for long-term wellness

Small wins add up to big transformations. Mochi reminds us to focus on what’s good and use it to build the life we envision.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

Personalized care for long-term wellness

Small wins add up to big transformations. Mochi reminds us to focus on what’s good and use it to build the life we envision.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

Personalized care for long-term wellness

Small wins add up to big transformations. Mochi reminds us to focus on what’s good and use it to build the life we envision.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.